{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:12:53Z","timestamp":1777975973508,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jinf.2017.02.006","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T19:03:14Z","timestamp":1487790194000},"page":"450-455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of underlying immune compromise on the manifestations and outcomes of group A streptococcal bacteremia"],"prefix":"10.1016","volume":"74","author":[{"given":"Kathleen A.","family":"Linder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leen","family":"Alkhouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1677-3994","authenticated-orcid":false,"given":"Mayur","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Alangaden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Kauffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa H.","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jinf.2017.02.006_bib1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/cid\/ciw248","article-title":"Epidemiology of invasive group A streptococcal infections in the United States, 2005\u20132012","volume":"63","author":"Nelson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2017.02.006_bib2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3201\/eid0908.020745","article-title":"Invasive group A streptococcal disease: risk factors for adults","volume":"9","author":"Factor","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2017.02.006_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s15010-002-1182-6","article-title":"Invasive group A streptococcal infections in a large tertiary care center: epidemiology, characteristics and outcome","volume":"30","author":"Ben-Abraham","year":"2002","journal-title":"Infection"},{"issue":"7","key":"10.1016\/j.jinf.2017.02.006_bib4","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/JCM.00422-08","article-title":"Epidemiology of severe Streptococcus pyogenes disease in Europe","volume":"46","author":"Lamagni","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.jinf.2017.02.006_bib5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/cid\/civ1032","article-title":"The impact of obesity and diabetes on the risk of disease and death due to invasive group A Streptococcus infections in adults","volume":"62","author":"Langley","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2017.02.006_bib6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/cid\/cis422","article-title":"Evolving epidemiologic characteristics of invasive group A streptococcal disease in Utah, 2002\u20132010","volume":"55","author":"Stockmann","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jinf.2017.02.006_bib7","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/657068","article-title":"Epidemic of group A Streptococcus M\/emm59 causing invasive disease in Canada","volume":"51","author":"Tyrrell","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2017.02.006_bib8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00005792-199707000-00002","article-title":"Group A streptococcal bacteremia: a 10-year prospective study","volume":"76","author":"Bernaldo de Quir\u00f3s","year":"1997","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.jinf.2017.02.006_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1399-3062.2005.00088.x","article-title":"Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients","volume":"7","author":"Almyroudis","year":"2005","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2017.02.006_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s15010-011-0229-y","article-title":"Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients","volume":"40","author":"Mikulska","year":"2012","journal-title":"Infection"},{"issue":"2","key":"10.1016\/j.jinf.2017.02.006_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/bmt.2009.149","article-title":"Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention","volume":"45","author":"Safdar","year":"2010","journal-title":"Bone Marrow Transpl"},{"issue":"8","key":"10.1016\/j.jinf.2017.02.006_bib12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1086\/605664","article-title":"Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents","volume":"49","author":"Nucci","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2017.02.006_bib13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/lt.22296","article-title":"Spectrum of early-onset and late-onset bacteremias after liver transplantation: implications for management","volume":"17","author":"Lee","year":"2011","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.jinf.2017.02.006_bib14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1399-3062.2009.00422.x","article-title":"Clinical spectrum of gram-positive infections in lung transplantation","volume":"11","author":"Gupta","year":"2009","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2017.02.006_bib15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/clinids\/21.5.1077","article-title":"Infections in liver transplant recipients","volume":"21","author":"Winston","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2017.02.006_bib16","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/tri.12808","article-title":"Clinical and microbiological epidemiology of early and late infectious complications among solid-organ transplant recipients requiring hospitalization","volume":"29","author":"Hamandi","year":"2016","journal-title":"Transpl Int"},{"issue":"2","key":"10.1016\/j.jinf.2017.02.006_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jinf.2012.11.007","article-title":"Review of streptococcal bloodstream infections at a comprehensive cancer care center, 2000\u20132011","volume":"66","author":"Shelburne","year":"2013","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.jinf.2017.02.006_bib18","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/515012","article-title":"Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome","volume":"27","author":"Eriksson","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2017.02.006_bib19","first-page":"1498","article-title":"Streptococcal toxic shock syndrome complicating necrotizing fasciitis in a renal transplant patient","volume":"9","author":"Cohen","year":"1994","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"10.1016\/j.jinf.2017.02.006_bib20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ndt\/17.1.150","article-title":"Group A streptococcal bacteraemia and necrotizing fasciitis in a renal transplant patient: a case for intravenous immunoglobulin therapy","volume":"17","author":"Korzets","year":"2002","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"10.1016\/j.jinf.2017.02.006_bib21","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/317460","article-title":"Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer","volume":"31","author":"Marron","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2017.02.006_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(03)00576-0","article-title":"Molecular basis of group A streptococcal virulence","volume":"3","author":"Bisno","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2017.02.006_bib23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13054-016-1398-y","article-title":"Neutropenic sepsis is associated with distinct clinical and biological characteristics: a cohort study of severe sepsis","volume":"20","author":"Reilly","year":"2016","journal-title":"Crit Care"},{"issue":"9","key":"10.1016\/j.jinf.2017.02.006_bib24","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.4049\/jimmunol.177.9.6405","article-title":"HIV and other lentiviral infections cause defects in neutrophil chemotaxis, recruitment, and cell structure: immunorestorative effects of granulocyte-macrophage colony-stimulating factor","volume":"177","author":"Heit","year":"2006","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.jinf.2017.02.006_bib25","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/CMR.13.3.470","article-title":"Pathogenesis of group A streptococcal infections","volume":"13","author":"Cunningham","year":"2000","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.jinf.2017.02.006_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1086\/653116","article-title":"Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections","volume":"51","author":"Johansson","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2017.02.006_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.00101-13","article-title":"Disease manifestations and pathogenic mechanisms of group A Streptococcus","volume":"27","author":"Walker","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.jinf.2017.02.006_bib28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ccc.2013.03.012","article-title":"Toxic shock syndrome: major advances in pathogenesis, but not treatment","volume":"29","author":"Low","year":"2013","journal-title":"Crit Care Clin"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445317300555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445317300555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:24:49Z","timestamp":1759008289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445317300555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0163445317300555"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2017.02.006","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of underlying immune compromise on the manifestations and outcomes of group A streptococcal bacteremia","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2017.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}